piperacillin has been researched along with clindamycin in 81 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 19 (23.46) | 18.7374 |
1990's | 19 (23.46) | 18.2507 |
2000's | 24 (29.63) | 29.6817 |
2010's | 14 (17.28) | 24.3611 |
2020's | 5 (6.17) | 2.80 |
Authors | Studies |
---|---|
Beceiro, A; Bou, G; Canle, D; Fernández, A; Lasa, I; Latasa, C; Mallo, S; Molina, F; Pérez, A; Pérez, S; Poza, M; Tomás, Mdel M; Villanueva, R | 1 |
Amblard, M; Bastide, L; Gualtieri, M; Leonetti, JP; Martinez, J; Pugniere, M; Roquet, F; Villain-Guillot, P | 1 |
Calvet, L; Devine, R; Dubreuil, L; Jean-Pierre, H; Jumas-Bilak, E; Marchandin, H; Mercier, G; Morio, F | 1 |
Baudry, PJ; DeCorby, M; Hoban, DJ; Johnson, J; Karlowsky, JA; Lagacé-Wiens, P; Laing, N; McCracken, M; Mulvey, MR; Nichol, KA; Tailor, F; Vashisht, R; Walkty, A; Weshnoweski, B; Wierzbowski, A; Zhanel, GG | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Betriu, C; Culebras, E; Gómez, M; López, F; Picazo, JJ; Rodríguez-Avial, I | 1 |
Hsueh, PR; Huang, YT; Liao, CH; Lin, HY; Liu, CY; Yen, LC | 1 |
Karlowsky, JA; Laing, NM; Zhanel, GG | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Jacobus, NV; McDermott, LA; Snydman, DR | 1 |
Appelbaum, PC; Ednie, LM | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Hafkin, B; Hoban, DJ; Kaplan, N; Karlowsky, JA; Zhanel, GG | 1 |
Ichiishi, S; Mikamo, H; Nakao, K; Shibata, T; Tanaka, K; Watanabe, K | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chong, Y; Jeong, SH; Kim, MS; Lee, K; Lee, Y; Park, Y; Yong, D | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Spencer, RC; Wilcox, MH; Winstanley, TG | 1 |
Kaneko, K; Motegi, M; Sando, Y; Sugita, Y; Takayanagi, N; Ubukata, M | 1 |
Karnes, HT; Reinhard, M; Rogers, E; Sarkar, MA; Wells, B | 1 |
Ahrne, H; Eilard, T; Eriksson, I; Lausen, I; Maller, R | 1 |
Farnè, C; Piccione, E; Sesti, F | 1 |
Abfalter, E; Müller, E; Peer, D; Schröcksnadel, H; Sölder, E | 1 |
Acar, B; Zissis, NP | 1 |
Hancock, KC; Harrison, CR; Satin, AJ; Zahn, CM | 1 |
Baltch, AL; Bassey, C; Fanciullo, G; Smith, RP | 1 |
Edwards, JR; Turner, PJ | 1 |
Brattström, C; Malmborg, AS; Tydén, G | 1 |
Heard, MC; Hemsell, DL; Hemsell, PG; Nobles, BJ | 1 |
Jeljaszewicz, J; Ko, HL; Pulverer, G; Roszkowski, K; Roszkowski, W; van der Waaij, D | 1 |
Gunning, JE | 1 |
Bosso, JA; Marble, DA; Townsend, RJ | 1 |
Barry, AL; Jones, RN; Packer, RR | 1 |
Sabath, LD; Tack, KJ | 1 |
Jeljaszewicz, J; Ko, HL; Pulverer, G; Roszkowski, K; Roszkowski, W | 2 |
Citron, DM; Goldstein, EJ | 1 |
Fribourg, S | 1 |
Forster, GE; Munday, PE | 1 |
Fass, RJ; Helsel, VL | 1 |
Milatović, D | 1 |
Lahnborg, G; Nord, CE | 1 |
Liu, CY; Lui, WY; Shyr, YM; Su, CH; Wang, LS | 1 |
Appelbaum, PC; Jacobs, MR; Pankuch, GA | 1 |
Faro, S; O'Brien, WF; Roy, S; Sanfilippo, JS; Seidlin, M; Sweet, RL | 1 |
Barie, PS; Cheadle, WG; Fink, MP; Garber, GE; Hebert, JC; Laverdiere, M; Polk, HC; Wilson, SE | 1 |
Cherubin, CE; Citron, DM; Goldstein, EJ; Hillier, SL | 1 |
Aldridge, KE; Johnson, WD | 1 |
Büyükpamukçu, N; Ciftci, AO; Hiçsonmez, A; Tanyel, FC | 1 |
Falagas, ME; McDermott, L; Snydman, DR | 1 |
Akita, S; Ito, Y; Kato, M; Kato, N; Miyata, H; Miyazaki, T; Mizuta, K; Watanabe, K | 1 |
Deguchi, K; Ishihara, R; Ishii, Y; Nakazawa, A; Suzuki, Y | 1 |
Betriu, C; Gómez, M; Palau, ML; Picazo, JJ; Sánchez, A | 1 |
Baddour, LM; Googe, PB; Prince, TL | 1 |
Abi-Said, D; Bivins, C; Hachem, R; Hanna, H; Huaringa, A; Raad, I; Sukumaran, A; Thornby, J; Walsh, G; Whimbey, E | 1 |
Kot, K; Meszaros, J; Rokosz, A; Sawicka-Grzelak, A; Łuczak, M | 1 |
Hara, K; Hayakawa, T; Hirakata, Y; Izumikawa, K; Kohno, S; Sasaki, E; Shioshita, K; Yamanouchi, H | 1 |
Bark, B; Perlick, E; Stöver, B | 1 |
Ford, HR; Gaines, BA; Nadler, EP; Reblock, KK | 1 |
Dias, MA; Konefal, SH; McLaughlin, MR; Wadie, GM | 1 |
Mullick, RN; Zissis, NP | 1 |
Borzsei, L; Horváth, A; Kocsis, B; Koós, Z; Mintál, T; Nyárády, J | 1 |
Gurkan, E; Hutton-Thomas, R; Lakticová, V; Meyer, M; Rice, LB | 1 |
Batista, N; Fernández, MP; Gambra, ML; Rodríguez, L | 1 |
Fanning, KJ; Prins, JB; Roberts, MS; Robertson, TA | 1 |
Funke, M; Janssen, E; Rodloff, AC; Schaumann, R | 1 |
Kumar, A; Shahi, SK; Singh, VK | 1 |
Baek, MS; Bristow, J; Chen, F; Cheng, J; Fujimura, K; Lynch, SV; Panzer, AR; Peng, Z; Singh, G; Sorek, R; Srinivasan, R; Tringe, SG; Weng, L; Wiener-Kronish, JP | 1 |
Pineda, LC; Watt, KM | 1 |
Bhattacharya, S; Bhaumik, J; Chandy, M; Goel, G; Mukherjee, S | 1 |
Eng, LC; Kwang, LL; Ng, LS; Rao, S; Tan, TY | 1 |
Jensen, BH; Justesen, US; Krogfelt, KA; Petersen, AM; Sydenham, TV | 1 |
Cohen-Wolkowiez, M; Greenberg, RG; Rivera-Chaparro, ND | 1 |
Ledger, TS | 1 |
Nakahashi, H; Nakura, Y; Nomiyama, M; Ono, T; Tanaka, S; Tokuda, T; Tsumura, K; Yamamoto, T; Yanagihara, I | 1 |
AlAzmi, A; AlHashem, G; Jamal, W; Khodakhast, FB; Rotimi, VO; Sόki, J | 1 |
Chawla, K; Gupta, A; Kumar, A; Shenoy, PA | 1 |
Li, J; Li, N; Liu, B; Lü, X; Wang, H; Zhang, Y | 1 |
Chen, CH; Ho, MW; Hsueh, PR; Ko, WC; Lin, HH; Tseng, KH; Wu, PH | 1 |
Arriaga-García, FJ; Medellín-Garibay, SE; Milán-Segovia, RDC; Pérez-González, LF; Rodríguez-Báez, AS; Romano-Moreno, S; Velarde-Salcedo, R | 1 |
2 review(s) available for piperacillin and clindamycin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
New antibiotic dosing in infants.
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Clindamycin; Humans; Infant; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Meropenem; Metronidazole; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Practice Guidelines as Topic; Thienamycins | 2015 |
10 trial(s) available for piperacillin and clindamycin
Article | Year |
---|---|
Efficacy and safety of amikacin in systemic infections when given as a single daily dose or in two divided doses. Scandinavian Amikacin Once Daily Study Group.
Topics: Adult; Aged; Amikacin; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Clindamycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Hearing; Humans; Male; Middle Aged; Penicillins; Piperacillin | 1991 |
Piperacillin alone vs triple antibiotic combination in gynecological infections.
Topics: Adult; Clindamycin; Drug Therapy, Combination; Endometritis; Female; Gentamicins; Humans; Pelvic Inflammatory Disease; Penicillin G; Piperacillin; Randomized Controlled Trials as Topic; Salpingitis | 1989 |
Piperacillin and a combination of clindamycin and gentamicin for the treatment of hospital and community acquired acute pelvic infections including pelvic abscess.
Topics: Abscess; Adult; Bacterial Infections; Clindamycin; Clinical Trials as Topic; Costs and Cost Analysis; Cross Infection; Drug Therapy, Combination; Female; Gentamicins; Humans; Pelvic Inflammatory Disease; Piperacillin; Random Allocation; Salpingitis | 1987 |
A comparison of piperacillin and clindamycin plus gentamicin in women with pelvic infections.
Topics: Abortion, Septic; Abscess; Adolescent; Adult; Bacterial Infections; Bacteroides Infections; Clindamycin; Clinical Trials as Topic; Combined Modality Therapy; Dilatation and Curettage; Drainage; Drug Therapy, Combination; Endometritis; Ethnicity; Female; Follow-Up Studies; Genital Diseases, Female; Gentamicins; Gonorrhea; Humans; Piperacillin; Pregnancy; Salpingitis | 1986 |
Results of the North American trial of piperacillin/tazobactam compared with clindamycin and gentamicin in the treatment of severe intra-abdominal infections. Investigators of the Piperacillin/Tazobactam Intra-abdominal Infection Study Group.
Topics: Abdomen; Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; beta-Lactamase Inhibitors; Clindamycin; Drug Therapy, Combination; Female; Gentamicins; Humans; Kidney; Kidney Function Tests; Male; Middle Aged; North America; Penicillanic Acid; Piperacillin; Tazobactam | 1994 |
Piperacillin/tazobactam in comparison with clindamycin plus gentamicin in the treatment of intra-abdominal infections.
Topics: Abdomen; Bacterial Infections; Clindamycin; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 1995 |
Piperacillin and tazobactam versus clindamycin and gentamicin in the treatment of hospitalized women with pelvic infection. The Piperacillin/tazobactam Study Group.
Topics: Bacterial Infections; beta-Lactamase Inhibitors; Clindamycin; Drug Administration Schedule; Drug Therapy, Combination; Endometritis; Female; Gentamicins; Humans; Pelvic Inflammatory Disease; Penicillanic Acid; Piperacillin; Tazobactam | 1994 |
Prospective randomized study of piperacillin/tazobactam therapy of surgically treated intra-abdominal infection. The Piperacillin/Tazobactam Intra-Abdominal Infection Study Group.
Topics: Abdomen; Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Appendicitis; Bacterial Infections; beta-Lactamase Inhibitors; Cholangitis; Cholecystitis; Clindamycin; Combined Modality Therapy; Diverticulitis; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Prospective Studies; Tazobactam | 1993 |
Comparative trial of four antibiotic combinations for perforated appendicitis in children.
Topics: Adolescent; Amebicides; Anti-Bacterial Agents; Antibiotic Prophylaxis; Appendicitis; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Clindamycin; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Intestinal Perforation; Male; Ornidazole; Penicillins; Piperacillin; Prospective Studies; Rupture, Spontaneous; Tobramycin; Treatment Outcome | 1997 |
Treatment of nosocomial postoperative pneumonia in cancer patients: a prospective randomized study.
Topics: Aged; Amikacin; Aztreonam; Chi-Square Distribution; Clindamycin; Cross Infection; Drug Therapy, Combination; Humans; Middle Aged; Neoplasms; Opportunistic Infections; Penicillanic Acid; Piperacillin; Pneumonia, Bacterial; Postoperative Complications; Prognosis; Prospective Studies; Tazobactam | 2001 |
69 other study(ies) available for piperacillin and clindamycin
Article | Year |
---|---|
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
Topics: Bacterial Proteins; Base Sequence; beta-Lactamases; Carrier Proteins; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genes, MDR; Genetic Vectors; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Porins | 2007 |
Structure-activity relationships of phenyl-furanyl-rhodanines as inhibitors of RNA polymerase with antibacterial activity on biofilms.
Topics: Animals; Anti-Bacterial Agents; Biofilms; CHO Cells; Cricetinae; Cricetulus; DNA-Directed RNA Polymerases; Furans; Gram-Positive Bacteria; Microbial Sensitivity Tests; Rhodanine; Staphylococcus epidermidis; Structure-Activity Relationship | 2007 |
Antimicrobial susceptibilities and clinical sources of Dialister species.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Species Specificity; Veillonellaceae | 2007 |
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Canada; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Population Surveillance | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Resistance trends of the Bacteroides fragilis group over a 10-year period, 1997 to 2006, in Madrid, Spain.
Topics: Anti-Bacterial Agents; Bacteroides; Bacteroides fragilis; Bacteroides Infections; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Spain; Species Specificity; Time Factors | 2008 |
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides fragilis; Bacteroides Infections; Blood; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Taiwan | 2008 |
In vitro activity of OPT-80 tested against clinical isolates of toxin-producing Clostridium difficile.
Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Cross Infection; Enterocolitis, Pseudomembranous; Glycosides; Humans; In Vitro Techniques; Microbial Sensitivity Tests | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
In vitro activities of doripenem, a new broad-spectrum carbapenem, against recently collected clinical anaerobic isolates, with emphasis on the Bacteroides fragilis group.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides fragilis; Carbapenems; Doripenem; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests | 2008 |
Antianaerobic activity of sulopenem compared to six other agents.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Gram-Negative Bacteria; Humans; Lactams; Microbial Sensitivity Tests; Prodrugs | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
Topics: Anti-Bacterial Agents; Benzofurans; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Enterobacteriaceae; Enterococcus; Microbial Sensitivity Tests; Moraxella catarrhalis; Pyrones; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus pneumoniae | 2009 |
Susceptibilities of 23 Desulfovibrio isolates from humans.
Topics: Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Clindamycin; Desulfovibrio; Fluoroquinolones; Humans; Metronidazole; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Antimicrobial susceptibility patterns for recent clinical isolates of anaerobic bacteria in South Korea.
Topics: Anti-Infective Agents; Aza Compounds; Bacteria, Anaerobic; Bacteroides fragilis; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Positive Cocci; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Republic of Korea | 2010 |
Effect of pH on antibiotics used to treat anaerobic infection.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Cefoxitin; Clindamycin; Drug Therapy, Combination; Hydrogen-Ion Concentration; Imipenem; Metronidazole; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Tazobactam | 1992 |
[Three cases of pulmonary actinomycosis].
Topics: Actinomycosis; Adult; Clindamycin; Humans; Lung; Lung Diseases; Male; Middle Aged; Penicillin G; Piperacillin; Pneumonectomy; Tomography, X-Ray Computed | 1992 |
Stability of clindamycin phosphate, ranitidine hydrochloride, and piperacillin sodium in polyolefin containers.
Topics: Chromatography, High Pressure Liquid; Clindamycin; Drug Packaging; Drug Stability; Freezing; Piperacillin; Polyenes; Ranitidine | 1991 |
[Medical treatment of pelvic inflammatory disease. A clinical study on the therapeutic effectiveness of piperacillin + erythromycin and of piperacillin + clindamycin + gentamycin].
Topics: Clindamycin; Drug Evaluation; Drug Therapy, Combination; Erythromycin; Female; Gentamicins; Hospitalization; Humans; Pelvic Inflammatory Disease; Piperacillin; Remission Induction | 1990 |
[Combined surgical-antibiotic therapy of actinomycosis of the adnexa].
Topics: Actinomycosis; Adult; Ampicillin; Clindamycin; Combined Modality Therapy; Fallopian Tube Diseases; Female; Humans; Intrauterine Devices; Middle Aged; Ovarian Diseases; Piperacillin | 1990 |
Relapsing Clostridium difficile toxin-associated colitis in ovarian cancer patients treated with chemotherapy.
Topics: Aged; Ampicillin; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clindamycin; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Gentamicins; Humans; Middle Aged; Ovarian Neoplasms; Piperacillin; Recurrence | 1989 |
In-vitro antimicrobial activity of enoxacin in combination with eight other antibiotics against Pseudomonas aeruginosa, Enterobacteriaceae and Staphylococcus aureus.
Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Cefsulodin; Clindamycin; Drug Combinations; Drug Synergism; Enoxacin; Enterobacteriaceae; Microbial Sensitivity Tests; Moxalactam; Naphthyridines; Oxacillin; Piperacillin; Pseudomonas aeruginosa; Staphylococcus aureus; Vancomycin | 1987 |
Worldwide assessment of the activity of cefotetan against clinical isolates.
Topics: Cefotetan; Cephalosporins; Clindamycin; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Information Systems; Metronidazole; Microbial Sensitivity Tests; Piperacillin | 1988 |
Penetration of clindamycin, cefoxitin, and piperacillin into pancreatic juice in man.
Topics: Adult; Cefoxitin; Clindamycin; Female; Half-Life; Humans; Injections, Intravenous; Male; Pancreas; Pancreas Transplantation; Pancreatic Juice; Piperacillin; Regression Analysis; Time Factors | 1988 |
Antibiotic treatment, intestinal aerobic microflora and experimental sarcoma L-1 growth in Balb/c-mice.
Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Cell Division; Clindamycin; Enterobacteriaceae; Escherichia coli; Gentamicins; Intestines; Mezlocillin; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Piperacillin; Sarcoma, Experimental | 1987 |
Stability of clindamycin phosphate with aztreonam, ceftazidime sodium, ceftriaxone sodium, or piperacillin sodium in two intravenous solutions.
Topics: Aztreonam; Ceftazidime; Ceftriaxone; Clindamycin; Drug Stability; Hydrogen-Ion Concentration; Injections, Intravenous; Piperacillin; Solutions; Temperature | 1986 |
BMY28142, cefbuperazone (T-1982), and Sch 34343. Antimicrobial activity against 94 anaerobes compared to seven other antimicrobial agents.
Topics: Anti-Bacterial Agents; Bacteroides; Cefepime; Cefoperazone; Cefoxitin; Cephalosporins; Cephamycins; Chloramphenicol; Clindamycin; Clostridium; Lactams; Metronidazole; Microbial Sensitivity Tests; Piperacillin | 1985 |
Increased minimum inhibitory concentrations with anaerobiasis for tobramycin, gentamicin, and amikacin, compared to latamoxef, piperacillin, chloramphenicol, and clindamycin.
Topics: Amikacin; Aminoglycosides; Anaerobiosis; Anti-Bacterial Agents; Chloramphenicol; Clindamycin; Enterobacter; Escherichia coli; Gentamicins; Humans; Klebsiella; Microbial Sensitivity Tests; Moxalactam; Piperacillin; Salmonella; Serratia; Staphylococcus; Streptococcus; Tobramycin | 1985 |
Antibiotics and immunomodulation: effects of cefotaxime, amikacin, mezlocillin, piperacillin and clindamycin.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Antibody Formation; Cefotaxime; Clindamycin; Hypersensitivity, Delayed; Immune System; Immunosuppressive Agents; In Vitro Techniques; Lymphocyte Activation; Male; Mezlocillin; Mice; Mice, Inbred BALB C; Piperacillin | 1985 |
Comparative in vitro activity of cefbuperazone against anaerobic bacteria isolated from community hospitals.
Topics: Bacteria, Anaerobic; Cefoxitin; Cephamycins; Clindamycin; Cross Infection; Hospitals, Community; Humans; Microbial Sensitivity Tests; Moxalactam; Piperacillin | 1985 |
Piperacillin versus clindamycin plus gentamicin for pelvic infections.
Topics: Clindamycin; Costs and Cost Analysis; Drug Therapy, Combination; Female; Genital Diseases, Female; Gentamicins; Humans; Infections; Piperacillin | 1985 |
Piperacillin versus clindamycin plus gentamicin.
Topics: Bacterial Infections; Clindamycin; Female; Gentamicins; Humans; Pelvic Inflammatory Disease; Piperacillin | 1985 |
In vitro activity of carumonam.
Topics: Anti-Bacterial Agents; Aztreonam; Clindamycin; Drug Synergism; Enterobacteriaceae; Gram-Negative Aerobic Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Nafcillin; Piperacillin; Tobramycin | 1985 |
Effects of cefotaxime, clindamycin, mezlocillin, and piperacillin on mouse sarcoma L-1 tumor.
Topics: Animals; Cefotaxime; Cell Line; Clindamycin; Cytotoxicity, Immunologic; Killer Cells, Natural; Lung Neoplasms; Male; Mezlocillin; Mice; Mice, Inbred BALB C; Piperacillin; Sarcoma, Experimental | 1984 |
Effect of subinhibitory antibiotic concentrations on the phagocytosis of Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Blood Bactericidal Activity; Cefotaxime; Cefotiam; Clindamycin; Doxycycline; Humans; Neutrophils; Penicillin G; Penicillins; Phagocytosis; Piperacillin; Staphylococcus aureus; Vancomycin | 1982 |
Efficacy of piperacillin/tazobactam in the treatment of experimental intra-abdominal infections.
Topics: Abdomen; Animals; Bacterial Infections; beta-Lactamase Inhibitors; Clindamycin; Drug Therapy, Combination; Gentamicins; Imipenem; Male; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Rats; Rats, Sprague-Dawley; Tazobactam | 1994 |
Susceptibilities of 428 gram-positive and -negative anaerobic bacteria to Bay y3118 compared with their susceptibilities to ciprofloxacin, clindamycin, metronidazole, piperacillin, piperacillin-tazobactam, and cefoxitin.
Topics: Anti-Infective Agents; Bacteria, Anaerobic; beta-Lactamases; Cefoxitin; Ciprofloxacin; Clindamycin; Drug Therapy, Combination; Fluoroquinolones; Gram-Negative Anaerobic Bacteria; Gram-Positive Bacteria; Metronidazole; Microbial Sensitivity Tests; Piperacillin | 1993 |
Comparative susceptibility of the Bacteroides fragilis group species and other anaerobic bacteria to meropenem, imipenem, piperacillin, cefoxitin, ampicillin/sulbactam, clindamycin and metronidazole.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides fragilis; Cefoxitin; Clindamycin; Drug Resistance, Microbial; Imipenem; Meropenem; Metronidazole; Microbial Sensitivity Tests; Piperacillin; Sulbactam; Thienamycins | 1993 |
A comparison of susceptibility results of the Bacteroides fragilis group and other anaerobes by traditional MIC results and statistical methods.
Topics: Bacteria, Anaerobic; Bacteroides; Bacteroides fragilis; beta-Lactam Resistance; Cefotaxime; Cefoxitin; Ceftizoxime; Ceftriaxone; Cephalosporins; Clindamycin; Clostridium; Drug Resistance, Microbial; Eubacterium; Metronidazole; Microbial Sensitivity Tests; Penicillins; Peptostreptococcus; Piperacillin; Prevotella; Veillonella | 1997 |
Effect of pH on in vitro antimicrobial susceptibility of the Bacteroides fragilis group.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteroides fragilis; Ciprofloxacin; Clindamycin; Drug Therapy, Combination; Fluoroquinolones; Hydrogen-Ion Concentration; Imipenem; Meropenem; Microbial Sensitivity Tests; Naphthyridines; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Thienamycins | 1997 |
[Retropharyngeal abscess in an adult and an elderly woman].
Topics: Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Clindamycin; Female; Humans; Male; Penicillins; Piperacillin; Retropharyngeal Abscess | 1998 |
[Antimicrobial activities of clindamycin against clinical isolated Streptococcus pneumoniae].
Topics: Anti-Bacterial Agents; Cefotiam; Ceftazidime; Cephalosporins; Clindamycin; Drug Resistance, Microbial; Erythromycin; Josamycin; Penicillins; Piperacillin; Streptococcus pneumoniae | 1997 |
In-vitro susceptibilities of species of the Bacteroides fragilis group to newer beta-lactam agents.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacteroides fragilis; beta-Lactamase Inhibitors; Cefoxitin; Ceftizoxime; Chloramphenicol; Clavulanic Acid; Clindamycin; Drug Therapy, Combination; Enzyme Inhibitors; Imipenem; Metronidazole; Mezlocillin; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Species Specificity; Sulbactam; Tazobactam; Thienamycins; Ticarcillin | 1999 |
Possible role of cellular immunity: a case of cellulitis.
Topics: Cellulitis; Clindamycin; Drug Eruptions; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Hypersensitivity, Delayed; Middle Aged; Nafcillin; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam; Vancomycin | 2001 |
[Use of the Etest method for antimicrobial susceptibility testing of obligate anaerobes].
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Clindamycin; Humans; Imipenem; Metronidazole; Microbial Sensitivity Tests; Piperacillin | 2001 |
[A successful treatment of Vibrio vulnificus infection].
Topics: Aged; Anti-Bacterial Agents; Clindamycin; Drug Therapy, Combination; Humans; Male; Penicillins; Piperacillin; Vibrio; Vibrio Infections | 2002 |
[Thoracic wall crossing (pseudo-?) tumor in a child: abscess-forming thoracic actinomycosis caused by Actinomyces meyeri et israeli].
Topics: Actinomyces; Actinomycosis; Anti-Infective Agents; beta-Lactamase Inhibitors; Child; Clindamycin; Diagnosis, Differential; Enzyme Inhibitors; Female; Humans; Lung Abscess; Penicillanic Acid; Piperacillin; Radiography, Thoracic; Tazobactam; Thoracic Diseases; Thoracic Wall; Tomography, X-Ray Computed; Ultrasonography | 2004 |
Monotherapy versus multi-drug therapy for the treatment of perforated appendicitis in children.
Topics: Ampicillin; Appendectomy; Appendicitis; Child; Clindamycin; Drug Combinations; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Postoperative Complications; Retrospective Studies | 2003 |
Cervical spondylodiscitis from an ingested pin: a case report.
Topics: Accidents; Adolescent; Amoxicillin-Potassium Clavulanate Combination; Antibiotic Prophylaxis; Bone Plates; Ceftriaxone; Cervical Vertebrae; Clindamycin; Combined Modality Therapy; Deglutition Disorders; Discitis; Diskectomy; Emergencies; Equipment Contamination; Follow-Up Studies; Foreign Bodies; Humans; Laryngoscopy; Larynx; Male; Neck Pain; Oxacillin; Paresthesia; Penicillanic Acid; Pharynx; Piperacillin; Piperacillin, Tazobactam Drug Combination; Radiography; Recurrence; Retropharyngeal Abscess; Spinal Fusion; Vancomycin; Wounds, Penetrating | 2005 |
Piperacillin vs gentamicin-clindamycin combination in intra-abdominal infections.
Topics: Abdominal Pain; Anti-Bacterial Agents; Bacterial Infections; Clindamycin; Clinical Trials as Topic; Controlled Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Piperacillin | 1989 |
Comparative study of antibiotic-containing polymethylmetacrylate capsules and beads.
Topics: Amikacin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Capsules; Clindamycin; Microspheres; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Polymethyl Methacrylate | 2006 |
Antibiotic-induced enterococcal expansion in the mouse intestine occurs throughout the small bowel and correlates poorly with suppression of competing flora.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Clavulanic Acids; Clindamycin; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Escherichia coli; Green Fluorescent Proteins; Intestine, Small; Metronidazole; Mice; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Ticarcillin | 2006 |
[Fournier's gangrene caused by Streptococcus agalactiae in a non-pregnant woman].
Topics: Adult; Anti-Bacterial Agents; Clindamycin; Combined Modality Therapy; Debridement; Diabetes Mellitus, Type 1; Disease Susceptibility; Drug Therapy, Combination; Female; Fournier Gangrene; Humans; Metronidazole; Obesity; Penicillanic Acid; Perineum; Piperacillin; Reoperation; Streptococcal Infections; Streptococcus agalactiae; Tazobactam | 2009 |
Changes in antibiotic distribution due to pancreatitis.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Clindamycin; Male; Meropenem; Organotin Compounds; Pancreatitis; Piperacillin; Rats; Rats, Wistar; Thienamycins | 2011 |
In vitro activities of clindamycin, imipenem, metronidazole, and piperacillin-tazobactam against susceptible and resistant isolates of Bacteroides fragilis evaluated by kill kinetics.
Topics: Anti-Infective Agents; Bacteroides fragilis; Clindamycin; Imipenem; Metronidazole; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Tazobactam | 2012 |
Detection of Escherichia coli and associated β-lactamases genes from diabetic foot ulcers by multiplex PCR and molecular modeling and docking of SHV-1, TEM-1, and OXA-1 β-lactamases with clindamycin and piperacillin-tazobactam.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Clindamycin; Diabetic Foot; Escherichia coli; Escherichia coli Infections; Gene Expression; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Multiplex Polymerase Chain Reaction; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Structural Homology, Protein; Structure-Activity Relationship | 2013 |
Rearrangement of a large novel Pseudomonas aeruginosa gene island in strains isolated from a patient developing ventilator-associated pneumonia.
Topics: Anti-Bacterial Agents; Clindamycin; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gene Rearrangement; Genetic Variation; Genome, Bacterial; Genomic Islands; Humans; Longitudinal Studies; Molecular Typing; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Pseudomonas Infections; Sequence Analysis, DNA | 2014 |
Epidemiology of antimicrobial resistance in an oncology center in eastern India.
Topics: Acinetobacter; Amikacin; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Cancer Care Facilities; Carbapenems; Ceftazidime; Ciprofloxacin; Clindamycin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Enterobacteriaceae; Feces; Fluconazole; Gentamicins; Humans; India; Methicillin-Resistant Staphylococcus aureus; Mycoses; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas; Yeasts | 2015 |
Clinical characteristics and antimicrobial susceptibilities of anaerobic bacteremia in an acute care hospital.
Topics: Anaerobiosis; Anti-Infective Agents; Bacteremia; Bacteria, Anaerobic; Bacteroides; Carbapenems; Clindamycin; Clostridium; Drug Resistance, Microbial; Fusobacterium; Gram-Positive Bacteria; Humans; Intraabdominal Infections; Metronidazole; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Propionibacterium; Retrospective Studies | 2017 |
Antimicrobial resistance in the Bacteroides fragilis group in faecal microbiota from healthy Danish children.
Topics: Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; Child; Clindamycin; Denmark; Drug Resistance, Bacterial; Feces; Humans; Meropenem; Metronidazole; Microbial Sensitivity Tests; Microbiota; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Surveys and Questionnaires; Thienamycins | 2017 |
Dosing antibiotics in neonates: review of the pharmacokinetic data.
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Birth Weight; Body Size; Cephalosporins; Child; Clindamycin; Glycopeptides; Humans; Infant; Infant, Newborn; Medication Reconciliation; Meropenem; Metronidazole; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Thienamycins | 2017 |
Topics: Amoxicillin; Anti-Bacterial Agents; Clavulanic Acid; Clindamycin; Diagnosis, Differential; Female; Humans; Middle Aged; Penicillanic Acid; Penicillin G; Peritonitis; Piperacillin; Streptococcal Infections; Streptococcus pyogenes; Tazobactam; Treatment Outcome | 2018 |
New antibiotic regimen for preterm premature rupture of membrane reduces the incidence of bronchopulmonary dysplasia.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Azithromycin; Bronchopulmonary Dysplasia; Cefmetazole; Clindamycin; Drug Therapy, Combination; Female; Fetal Membranes, Premature Rupture; Humans; Incidence; Outcome Assessment, Health Care; Piperacillin; Pregnancy; Retrospective Studies; Sulbactam | 2019 |
Prevalence and antimicrobial susceptibility of enterotoxigenic extra-intestinal Bacteroides fragilis among 13-year collection of isolates in Kuwait.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Toxins; Bacteroides fragilis; Bacteroides Infections; Cefoxitin; Clindamycin; Drug Resistance, Bacterial; Feces; Female; Humans; Imipenem; Kuwait; Male; Meropenem; Metronidazole; Microbial Sensitivity Tests; Piperacillin; Prevalence; Prospective Studies; Respiratory Tract Infections; Sepsis; Tigecycline; Wound Infection | 2020 |
Clinico-microbiological profile of
Topics: Anti-Bacterial Agents; Bacterial Infections; Bacteroides fragilis; Chloramphenicol; Clindamycin; Drug Resistance, Bacterial; Humans; Imipenem; Metronidazole; Microbial Sensitivity Tests; Piperacillin | 2021 |
Antibiotic susceptibility and biofilm-forming ability of Veillonella strains.
Topics: Ampicillin; Anti-Bacterial Agents; Biofilms; Cefoxitin; Clindamycin; Humans; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Piperacillin; Tazobactam; Tetracyclines; Vancomycin; Veillonella | 2022 |
Geographic patterns of antimicrobial susceptibilities for Bacteroides spp. worldwide: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) programme, 2007-2020.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteroides fragilis; Bacteroides Infections; Cefoxitin; Clindamycin; Humans; Leadership; Meropenem; Microbial Sensitivity Tests; Piperacillin; Tazobactam; Tigecycline | 2023 |
Model-informed precision dosing of antimicrobial drugs in pediatrics: experiences from a pilot scale program.
Topics: Anti-Bacterial Agents; Bayes Theorem; Child; Clindamycin; Critical Illness; Fluconazole; Humans; Linezolid; Meropenem; Metronidazole; Neoplasms; Piperacillin; Vancomycin | 2023 |